NCT06902623View on ClinicalTrials.gov

Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2030

Conditions
Oropharyngeal CancersHPVTonsil CancerBase of Tongue Cancer
Interventions
RADIATION

Radiation

Radiation only to 66Gy

Trial Locations (2)

20007

RECRUITING

Medstar Georgetown University Hospital, Washington D.C.

20735

RECRUITING

Medstar Southern Maryland Hospital Center, Clinton

All Listed Sponsors
lead

Georgetown University

OTHER